News

2019 Carterra Symposia

View the slides of the presentations from the therapeutic antibody revolution in the post genomics era symposia.

Read More

Bristol-Myers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe

Read More

Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.

Read More

GEN Article: A Therapeutic Antibody Characterization Trinity Accelerates Drug Development

The three core applications of high throughput SPR that form the antibody characterization trinity are capture kinetics, epitope binning, and epitope mapping. Together, they provide a comprehensive characterization of antibody libraries with minimal sample consumption, enabling more confident decisions to be made earlier and obviating the need for preliminary ELISA screening.

Read More

BioTechniques Article on Accelerating Biotherapeutic Discovery with High Throughput SPR

High throughput SPR is revolutionizing antibody screening for drug discovery, allowing screening and characterization to be accomplished in the same step, at the very beginning of the discovery process.

Read More

SLAS Invites Yasmina Abdiche to Present Current Advancements in Antibody Discovery

Accelerate library-to-lead triage of antibody libraries using high throughput SPR.

Read More

Presentation and Poster at Antibody Engineering & Therapeutics

Daniel Bedinger, PhD, our West Coast Senior Field Applications Scientist spoke about accelerating your antibody discovery with high throughput Array SPR.

Read More

Carterra Continues Successful Antibody Discovery Seminars with new US East Coast Event

Industry leaders gather in Cambridge, MA on December 5, 2018 to discuss innovative methods for accelerating antibody discovery.

Read More

Presentation and Poster at PEGS Europe

Phil Leighton, PhD, Director of Molecular Biology at Ligand Pharmaceuticals spoke about epitope mapping of human antibodies from transgenic chickens.

Read More

Antibody Discovery Industry Leaders Speak at Carterra’s September 18, 2018 Seminar

Array SPR has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step.

Read More